Most homeowners are not primarily concerned about what is sitting on a wall, a countertop, or a floor. They are concerned about what they are being exposed to, which means what they are inhaling. Understanding environmental mycotoxin testing is key to clarifying this confusion, as it reveals how airborne mycotoxins, dust, and surface residues behave differently.
Many environmental mycotoxin tests and treatment claims focus on surfaces or dust, while the main exposure pathway inside a home is the air. This guide explains how airborne mycotoxins, dust, and surface residues behave differently and what those differences mean for interpreting your environmental mycotoxin test results.
When different sample types are compared as if they are interchangeable, the result is often a false contradiction that leads to wrong decisions.
"What is on a surface is not always what is in the air" (Nazaroff, 2014; Morawska & Nazaroff, 2013).
What is Environmental Mycotoxin Testing and What Does It Measure?
Environmental mycotoxin testing is the measurement of chemically identifiable mycotoxins or mycotoxin-related compounds, secondary metabolites produced by certain molds, present in indoor spaces. Depending on the method used, testing can evaluate material present in the air, settled in dust, or attached to surfaces. Each approach samples a different part of the indoor environment and must be interpreted based on how exposure actually occurs.
At its core, an environmental mycotoxin test does not determine whether something is dangerous or whether a treatment “worked.” A laboratory analysis simply identifies whether chemically recognizable mycotoxin-related material is present in the collected sample. All conclusions about health relevance, exposure, or remediation effectiveness come later and depend on how the result is interpreted and which environmental zone was sampled.
In practical terms, environmental mycotoxin testing answers one basic question:
Is chemically recognizable mycotoxin-related material present in this sample?
Everything else, including health relevance and remediation performance, comes after that and depends on how the result is interpreted (National Research Council, 1983).
The Three Environmental Zones in Your Home
Indoor environments contain multiple zones where mycotoxin-related material can be measured. Each zone represents a different part of the home and answers a different question about presence, accumulation, or potential exposure. Understanding how these zones behave helps explain why air, dust, and surface mycotoxin test results do not always match. To fully grasp what environmental mycotoxin testing is, let’s explore the three environmental zones in your home and how each informs different aspects of detection.
Air: The Breathing Zone and Airborne Mycotoxin Testing
Air sampling measures what is suspended in the breathing zone at the time the sample is collected. This zone most directly reflects potential inhalation exposure because it captures fine particles that remain airborne and can be breathed into the lungs.
If your main concern is what you are being exposed to, then airborne environmental mycotoxin testing provides the most directly relevant information (Hinds, 1999; Morawska & Nazaroff, 2013).
Dust: The Historical Record and Dust Mycotoxin Testing
Dust sampling reflects material that has settled out of the air over time and accumulated on floors, furniture, and other surfaces. Because dust represents past conditions rather than what is currently airborne, results often reflect historical accumulation rather than present exposure.
After effective cleaning, there is often not enough remaining dust to reliably characterize mycotoxin levels, which means a non-detect in dust is frequently expected.
A positive dust result often reflects cleaning and maintenance conditions and does not, by itself, describe what is currently suspended in the air or indicate the extent of environmental conditions throughout the home (Ferro et al., 2004; Nazaroff, 2014).
Surfaces: The Contact Zone and Surface Mycotoxin Testing
Surface swab sampling measures material that is adhered to specific locations such as walls, furniture, flooring, or other fixed surfaces. These tests are useful for evaluating localized residue, contact areas, or the effectiveness of cleaning efforts in targeted locations.
Because surface samples represent what is attached at a specific point in space, they do not describe what is suspended in the breathing zone or moving through the indoor air. As a result, surface mycotoxin test results should be interpreted as indicators of localized conditions rather than direct measures of inhalation exposure.
Why Exposure and Airborne Mycotoxins Matter More Than Surface Claims
In indoor environments, exposure occurs primarily through inhalation. While mycotoxin-related material can be found on surfaces or in settled dust, the pathway most relevant to human exposure inside a building is the air people breathe.
For mycotoxin exposure, the evidence comes from the air. Surface and dust results provide context, not inhalation insight.
Fine and ultrafine particles can remain suspended in the air for extended periods, move easily with airflow and everyday activity, and be inhaled deep into the lungs. These particles behave differently from larger particles that settle quickly onto surfaces or into dust reservoirs (Hinds, 1999; Morawska & Nazaroff, 2013).
A surface can appear clean, treated, or chemically altered while particle-associated material continues to circulate in the breathing zone. For this reason, changes observed on surfaces do not automatically indicate that airborne conditions have changed in the same way.
Without air samples collected before and after a treatment under comparable conditions, there is no direct evidence showing whether particle-associated material was reduced in the breathing zone or only altered on contact surfaces.
For homeowners seeking to understand what they are actually being exposed to, airborne data provides the most directly relevant information. Surface and dust results can offer useful context, but they answer different questions and should not be treated as interchangeable measures of exposure.
Why “Destroyed, Neutralized, or Denatured on the Surface” Does Not Automatically Mean “Gone from the Air”
Some companies present data showing that a product or treatment can “destroy,” “neutralize,” or “denature” mycotoxins on surfaces. These findings are often then used to suggest that the same result applies to the air.
What is often missing from these claims is airborne data.
Surface testing shows what happens on contact. Only air testing can show whether conditions in the breathing zone have changed.
Surface testing shows what happens to material that is adhered to a surface. Mycotoxin air testing shows what remains suspended in the breathing zone. These represent different parts of the indoor environment that behave differently.
Without air samples taken before and after a treatment under comparable conditions, there is no direct evidence showing whether particle-associated material was reduced in the air or only altered on contact surfaces.
For homeowners, this distinction matters because inhalation is the primary exposure pathway inside a building. Changes observed on surfaces do not automatically indicate that airborne conditions have changed in the same way.
What Homeowners Should Understand About Dust-Based Remediation Claims
Dust-based testing and remediation claims are often presented as evidence that indoor conditions have improved. In reality, dust results describe what has settled out of the air over time, not what is currently being inhaled.
Because dust represents accumulated material rather than active airborne conditions, changes in dust measurements frequently reflect cleaning practices, sampling location, or timing rather than a change in ongoing exposure. For this reason, dust results are best understood as historical context, not real-time indicators of what occupants are breathing.
In most cases, effective cleaning can remove the majority of visible and settled dust, leaving very little material available for sampling. When this occurs, non-detect or low dust results are common and should not be interpreted as proof that airborne conditions have been resolved.
It is also important to understand that dust measurements can vary widely from one surface or room to another. Localized dust results do not necessarily represent conditions throughout the entire home, nor do they directly indicate what remains suspended in the breathing zone.
For homeowners, dust-based data can be useful when interpreted appropriately, but it should not be relied upon as a standalone measure of exposure or remediation effectiveness. Understanding what dust results can and cannot show is an important part of interpreting environmental mycotoxin testing results correctly.
Why Particle Size Matters for What You Actually Inhale
Household dust is made up largely of coarse particles that settle quickly onto floors, furniture, and surfaces. These larger particles are more likely to be contacted by touch or cleaning than to remain suspended in the air.
By contrast, fine and ultrafine particles are much smaller and behave differently. They can stay airborne for long periods, move easily with airflow and everyday activity, and are more likely to be inhaled deep into the lungs.
Because mycotoxin-related compounds often travel attached to particles rather than as a free gas, understanding which particles stay airborne versus which settle into dust helps explain why dust results and air results do not always match (Hinds, 1999; Morawska & Nazaroff, 2013).
What a "Detect" on an Environmental Mycotoxin Air Test Means
When a lab reports a detect, it means the test identified chemical signals consistent with mycotoxins or closely related compounds in the air sample.
It does not automatically mean:
- A health risk has been confirmed
- A medical threshold has been exceeded
- A remediation failed
A detect simply means that chemically recognizable mycotoxin-related compounds were present in the environmental compartment that was sampled, at the time the sample was collected (Berthiller et al., 2013; EFSA, 2014).
How AMEA Aligns Airborne Mycotoxin Testing With International Standards
AMEA airborne environmental mycotoxin testing is designed to focus on the breathing-zone airborne fraction, using controlled air volumes and documented sampling conditions.
The collection approach aligns with internationally recognized principles for inhalable and aerosol-based environmental sampling, which define how airborne particles are captured in a way that reflects what occupants can inhale (Hinds, 1999; U.S. EPA, 2002).
This principles-based approach helps ensure that airborne samples are:
- Collected from the occupied breathing zone
- Measured over defined air volumes and time intervals
- Handled under documented chain-of-custody and quality controls
- Analyzed in a way that reflects particle-associated airborne material, rather than surface residue
Why Dust Sampling Has Practical Limits for Exposure Assessment
Unlike air sampling, dust sampling is not designed to directly assess inhalation-based exposure in occupied spaces.
After effective cleaning, there is often too little remaining dust to reliably characterize mycotoxin levels. In these cases, a non-detect is expected and does not indicate whether airborne conditions have changed.
A positive dust result often reflects housekeeping and maintenance conditions, not necessarily a need for whole-home environmental remediation (Nazaroff, 2014; Ferro et al., 2004).
How to Tell If Airborne Mycotoxins Were Actually Reduced
The strongest way to show improvement in the air is to compare mycotoxin air tests taken before and after a treatment under similar conditions.
Good airborne testing comparisons include:
- The same sampling time and air volume
- Notes on humidity, ventilation, and room activity
- More than one sample for confirmation
- Independent laboratory analysis when possible
Without air-based evidence, claims about improved breathing-zone conditions remain interpretive rather than exposure-aligned (U.S. EPA, 2002; National Research Council, 1983).
Air improvement can only be demonstrated by comparing airborne mycotoxin tests collected before and after treatment under comparable conditions.
Common Homeowner Scenarios Explained
1. Clean Surfaces but an Air Detect
This often means cleaning or chemical interaction occurred on surfaces, while fine particles continue to circulate in the air.
2. Clear Air but Dust Still Shows Mycotoxins
This usually means older material remains in settled dust even though current airborne conditions have improved.
3. Detects in All Areas
This suggests material is moving between air, dust, and surfaces. It does not automatically indicate a health risk or severity.
Differences between air, dust, and surface results are expected because each sample reflects a different part of the indoor environment.
How to Test for Environmental Mycotoxins in a Way That Matches Your Concern
When deciding how to approach environmental mycotoxin testing in your home, start by clarifying your primary concern. If it is primarily exposure risks, airborne methods are the way to go.
If your concern is cleaning effectiveness, historical buildup, or contact residue, dust and surface tests can provide useful supporting information.
The key is understanding that these methods answer different questions and should not be treated as interchangeable.
Not sure which test fits your situation? See our complete guide to the best mycotoxin test for your home.
Key Takeaway for Homeowners
In environmental mycotoxin testing, if the concern is exposure, the evidence needs to come from the air.
Surface and dust testing can show where material has settled or been cleaned, but they cannot, by themselves, confirm what is still being inhaled. Claims about airborne removal or exposure reduction require airborne data to support them.
Frequently Asked Questions
Dust testing can provide useful context, but it does not directly measure what you are breathing. A dust detect can reflect historical accumulation and housekeeping conditions, so it should not be used by itself to justify major remediation decisions. If the concern is exposure, pair dust context with breathing-zone airborne data.
After effective cleaning, there may be very little dust left to sample. A non-detect in dust can be expected in that situation and does not automatically mean airborne conditions improved. If you are trying to confirm exposure reduction, compare airborne samples collected under similar conditions.
Not by itself. A detect means chemically recognizable mycotoxin-related material was present in the sampled air at that time. Health relevance depends on concentration, duration, individual susceptibility, and how the result is interpreted in context.
Because air, dust, and surface samples represent different environmental zones. Air reflects what is suspended now, dust reflects what settled over time, and surfaces reflect what is adhered at a location. Differences are often expected and should be interpreted as different questions being answered.
The most direct approach is a before-and-after comparison of airborne mycotoxin tests collected with similar air volumes, timing, and documented conditions. Without comparable airborne data, improvement claims remain interpretive rather than exposure aligned.
Reference Guide
- National Research Council. (1983). Risk Assessment in the Federal Government: Managing the Process. National Academies Press. Link
- Hinds, W. C. (1999). Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles. Wiley. Link (PDF)
- Morawska, L., et al. (2013). Indoor aerosols: from personal exposure to risk assessment. Indoor Air, 23(6), 462-487. Link
- Nazaroff, W. W. (2004). Indoor particle dynamics. Indoor Air, 14(Suppl 7), 175-183. Link
- Ferro, A. R., Kopperud, R. J., & Hildemann, L. M. (2004). Source strengths for indoor human activities that resuspend particulate matter. Environmental Science & Technology, 38(6), 1759-1764. Link
- Berthiller, F., et al. (2013). Masked mycotoxins: A review. Molecular Nutrition & Food Research, 57(1), 165-186. Link
- European Food Safety Authority. (2014). Modified forms of mycotoxins in food and feed. EFSA Journal, 12(12), 3916. Link
- U.S. Environmental Protection Agency. (2002). Guidance on Environmental Data Verification and Validation. Link
- World Health Organization. (2006). Principles for Evaluating Health Risks in Children Associated with Exposure to Chemicals. Link
